Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5).

Gendrot M, Wague Gueye M, Tsombeng Foguim F, Madamet M, Wade KA, Bou Kounta M, Fall M, Diawara S, Benoit N, Lo G, Bercion R, Amalvict R, Mosnier J, Fall B, Briolant S, Diatta B, Pradines B.

Acta Trop. 2019 Aug;196:126-134. doi: 10.1016/j.actatropica.2019.05.020. Epub 2019 May 17.

PMID:
31108084
2.

Baseline Ex Vivo and Molecular Responses of Plasmodium falciparum Isolates to Piperaquine before Implementation of Dihydroartemisinin-Piperaquine in Senegal.

Robert MG, Foguim Tsombeng F, Gendrot M, Diawara S, Madamet M, Kounta MB, Wade KA, Fall M, Gueye MW, Benoit N, Nakoulima A, Bercion R, Amalvict R, Fall B, Wade B, Diatta B, Pradines B.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02445-18. doi: 10.1128/AAC.02445-18. Print 2019 May.

PMID:
30782997
3.

Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa.

Robert MG, Foguim Tsombeng F, Gendrot M, Mosnier J, Amalvict R, Benoit N, Torrentino-Madamet M, Pradines B; French National Reference Centre for Imported Malaria Study Group.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00374-18. doi: 10.1128/AAC.00374-18. Print 2018 Nov.

4.

The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates.

Gendrot M, Foguim FT, Robert MG, Amalvict R, Mosnier J, Benoit N, Madamet M, Pradines B; French National Reference Centre for Imported Malaria Study Group.

Malar J. 2018 Mar 12;17(1):108. doi: 10.1186/s12936-018-2252-2.

5.

Ex vivo activity of Proveblue, a methylene blue, against field isolates of Plasmodium falciparum in Dakar, Senegal from 2013-2015.

Fall B, Madamet M, Diawara S, Briolant S, Wade KA, Lo G, Nakoulima A, Fall M, Bercion R, Kounta MB, Amalvict R, Benoit N, Gueye MW, Diatta B, Wade B, Pradines B.

Int J Antimicrob Agents. 2017 Aug;50(2):155-158. doi: 10.1016/j.ijantimicag.2017.03.019. Epub 2017 Jul 6.

PMID:
28689867
6.

Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.

Diawara S, Madamet M, Kounta MB, Lo G, Wade KA, Nakoulima A, Bercion R, Amalvict R, Gueye MW, Fall B, Diatta B, Pradines B.

Malar J. 2017 Mar 16;16(1):118. doi: 10.1186/s12936-017-1773-4.

7.

Association between Polymorphisms in the Pfmdr6 Gene and Ex Vivo Susceptibility to Quinine in Plasmodium falciparum Parasites from Dakar, Senegal.

Gendrot M, Diawara S, Madamet M, Kounta MB, Briolant S, Wade KA, Fall M, Benoit N, Nakoulima A, Amalvict R, Diémé Y, Fall B, Wade B, Diatta B, Pradines B.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01183-16. doi: 10.1128/AAC.01183-16. Print 2017 Mar.

8.

Absence of Association between Polymorphisms in the RING E3 Ubiquitin Protein Ligase Gene and Ex Vivo Susceptibility to Conventional Antimalarial Drugs in Plasmodium falciparum Isolates from Dakar, Senegal.

Gendrot M, Fall B, Madamet M, Fall M, Wade KA, Amalvict R, Nakoulima A, Benoit N, Diawara S, Diémé Y, Diatta B, Wade B, Pradines B.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):5010-3. doi: 10.1128/AAC.03105-15. Print 2016 Aug.

9.

Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.

Fall B, Madamet M, Camara C, Amalvict R, Fall M, Nakoulima A, Diatta B, Diémé Y, Wade B, Pradines B.

Emerg Infect Dis. 2016 May;22(5):841-5. doi: 10.3201/eid2205.151321.

10.

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine.

Madamet M, Briolant S, Amalvict R, Benoit N, Bouchiba H, Cren J, Pradines B; French National Centre for Imported Malaria Study Group.

Parasit Vectors. 2016 Feb 9;9:77. doi: 10.1186/s13071-016-1358-z.

11.

K13-Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014.

Torrentino-Madamet M, Collet L, Lepère JF, Benoit N, Amalvict R, Ménard D, Pradines B.

Antimicrob Agents Chemother. 2015 Dec;59(12):7878-81. doi: 10.1128/AAC.01251-15. Epub 2015 Sep 28.

12.

Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.

Pascual A, Madamet M, Briolant S, Gaillard T, Amalvict R, Benoit N, Travers D, Pradines B; French National Reference Centre for Imported Malaria Study Group.

Malar J. 2015 Feb 5;14:49. doi: 10.1186/s12936-015-0586-6.

13.

Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.

Torrentino-Madamet M, Fall B, Benoit N, Camara C, Amalvict R, Fall M, Dionne P, Ba Fall K, Nakoulima A, Diatta B, Diemé Y, Ménard D, Wade B, Pradines B.

Malar J. 2014 Dec 4;13:472. doi: 10.1186/1475-2875-13-472.

14.

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action.

Navarro M, Castro W, Madamet M, Amalvict R, Benoit N, Pradines B.

Malar J. 2014 Dec 3;13:471. doi: 10.1186/1475-2875-13-471.

15.

1H-1,2,3-triazole tethered isatin-ferrocene conjugates: Synthesis and in vitro antimalarial evaluation.

Kumar K, Pradines B, Madamet M, Amalvict R, Benoit N, Kumar V.

Eur J Med Chem. 2014 Nov 24;87:801-4. doi: 10.1016/j.ejmech.2014.10.024. Epub 2014 Oct 13.

PMID:
25440881
16.

1H-1,2,3-triazole tethered mono- and bis-ferrocenylchalcone-β-lactam conjugates: synthesis and antimalarial evaluation.

Kumar K, Pradines B, Madamet M, Amalvict R, Kumar V.

Eur J Med Chem. 2014 Oct 30;86:113-21. doi: 10.1016/j.ejmech.2014.08.053. Epub 2014 Aug 16.

PMID:
25147153
17.

In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum.

Dormoi J, Savini H, Amalvict R, Baret E, Pradines B.

Malar J. 2014 May 25;13:189. doi: 10.1186/1475-2875-13-189.

18.

In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene.

Pascual A, Madamet M, Bertaux L, Amalvict R, Benoit N, Travers D, Cren J, Taudon N, Rogier C, Parzy D, Pradines B; French National Reference Centre for Imported Malaria Study Group.

Malar J. 2013 Nov 25;12:431. doi: 10.1186/1475-2875-12-431.

19.

Proveblue (methylene blue) as an antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatin.

Dormoi J, Pascual A, Briolant S, Amalvict R, Charras S, Baret E, Huyghues des Etages E, Feraud M, Pradines B.

Antimicrob Agents Chemother. 2012 Jun;56(6):3467-9. doi: 10.1128/AAC.06073-11. Epub 2012 Mar 5. No abstract available.

20.

The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates.

Briolant S, Bogreau H, Gil M, Bouchiba H, Baret E, Amalvict R, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2012 May;56(5):2750-2. doi: 10.1128/AAC.05618-11. Epub 2012 Feb 6.

21.

Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model.

Souraud JB, Briolant S, Dormoi J, Mosnier J, Savini H, Baret E, Amalvict R, Soulard R, Rogier C, Pradines B.

Malar J. 2012 Jan 10;11:13. doi: 10.1186/1475-2875-11-13.

22.

In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs.

Pascual A, Henry M, Briolant S, Charras S, Baret E, Amalvict R, Huyghues des Etages E, Feraud M, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2011 May;55(5):2472-4. doi: 10.1128/AAC.01466-10. Epub 2011 Feb 22.

23.

In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo.

Briolant S, Pelleau S, Bogreau H, Hovette P, Zettor A, Castello J, Baret E, Amalvict R, Rogier C, Pradines B.

Malar J. 2011 Feb 11;10:37. doi: 10.1186/1475-2875-10-37.

24.

Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs.

Pascual A, Basco LK, Baret E, Amalvict R, Travers D, Rogier C, Pradines B.

Malar J. 2011 Jan 14;10:8. doi: 10.1186/1475-2875-10-8.

25.

Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum.

Pradines B, Briolant S, Henry M, Oeuvray C, Baret E, Amalvict R, Didillon E, Rogier C.

Malar J. 2010 Nov 25;9:339. doi: 10.1186/1475-2875-9-339.

26.

Malaria transmission and insecticide resistance of Anopheles gambiae in Libreville and Port-Gentil, Gabon.

Mourou JR, Coffinet T, Jarjaval F, Pradines B, Amalvict R, Rogier C, Kombila M, Pagès F.

Malar J. 2010 Nov 11;9:321. doi: 10.1186/1475-2875-9-321.

27.

Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum.

Briolant S, Henry M, Oeuvray C, Amalvict R, Baret E, Didillon E, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2010 Sep;54(9):3537-44. doi: 10.1128/AAC.00183-10. Epub 2010 Jun 14.

28.

Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.

Wurtz N, Briolant S, Gil M, Parquet V, Henry M, Baret E, Amalvict R, Almeras L, Rogier C, Pradines B.

J Antimicrob Chemother. 2010 Jul;65(7):1387-94. doi: 10.1093/jac/dkq173. Epub 2010 May 25.

PMID:
20501488
29.

Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.

Parquet V, Henry M, Wurtz N, Dormoi J, Briolant S, Gil M, Baret E, Amalvict R, Rogier C, Pradines B.

Malar J. 2010 May 25;9:139. doi: 10.1186/1475-2875-9-139.

30.

Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin.

Savini H, Souraud JB, Briolant S, Baret E, Amalvict R, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2010 Feb;54(2):966-7. doi: 10.1128/AAC.01006-09. Epub 2009 Nov 30. No abstract available.

31.

Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria.

Parquet V, Briolant S, Torrentino-Madamet M, Henry M, Almeras L, Amalvict R, Baret E, Fusaï T, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2009 Jun;53(6):2248-52. doi: 10.1128/AAC.01462-08. Epub 2009 Mar 23.

32.

Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.

Henry M, Briolant S, Zettor A, Pelleau S, Baragatti M, Baret E, Mosnier J, Amalvict R, Fusai T, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2009 May;53(5):1926-30. doi: 10.1128/AAC.01243-08. Epub 2009 Mar 9.

33.

Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malaria.

Henry M, Alibert S, Baragatti M, Mosnier J, Baret E, Amalvict R, Legrand E, Fusai T, Barbe J, Rogier C, Pagès JM, Pradines B.

Med Chem. 2008 Sep;4(5):426-37.

PMID:
18782039
34.

In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.

Henry M, Briolant S, Fontaine A, Mosnier J, Baret E, Amalvict R, Fusaï T, Fraisse L, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2008 Aug;52(8):2755-9. doi: 10.1128/AAC.00060-08. Epub 2008 May 27.

35.

First record of Aedes albopictus in Gabon.

Coffinet T, Mourou JR, Pradines B, Toto JC, Jarjaval F, Amalvict R, Kombila M, Carnevale P, Pages F.

J Am Mosq Control Assoc. 2007 Dec;23(4):471-2.

PMID:
18240521
36.

Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo.

Pradines B, Hovette P, Fusai T, Atanda HL, Baret E, Cheval P, Mosnier J, Callec A, Cren J, Amalvict R, Gardair JP, Rogier C.

J Clin Microbiol. 2006 Jul;44(7):2404-8.

Supplemental Content

Loading ...
Support Center